Spitz Tumor With SQSTM1::NTRK2 Fusion: A Clinicopathological Study of 5 Cases

Boulos Mansour1, Tomas Vanecek2, Liubov Kastnerova2

  • 1Department of Pathology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.

Insights

This study identifies a novel SQSTM1::NTRK2 gene fusion in five Spitz tumors, a rare type of melanocytic neoplasm. This finding advances understanding of the molecular drivers in Spitz tumor development.

Area of Science:

  • Dermatopathology
  • Molecular Oncology
  • Genetics

Background:

  • Spitz tumors are melanocytic neoplasms defined by specific molecular alterations.
  • Known driver events include rearrangements of BRAF, ALK, NTRK, MET, RET, ROS1, MAP3K8, or mutations in HRAS/MAP2K1.

Purpose of the Study:

  • To report and characterize Spitz tumors harboring a SQSTM1::NTRK2 fusion.
  • To investigate the clinicopathological and molecular features of these rare neoplasms.

Main Methods:

  • Histopathological examination of five Spitz tumors.
  • Next-generation sequencing (NGS) for molecular analysis.
  • Fluorescence in situ hybridization (FISH) in one case.

Main Results:

  • Five cases of Spitz tumors with a SQSTM1::NTRK2 fusion were identified.
  • Patients were women aged 30-50, with tumors on the lower extremity, forearm, and back.
  • Histopathology revealed superficial melanocytic proliferation with specific nesting patterns; one case resembled Reed nevus.

Conclusions:

  • The SQSTM1::NTRK2 fusion is a newly identified molecular event in Spitz tumors.
  • This fusion represents a potential driver alteration in a subset of these melanocytic neoplasms.

Related Concept Videos